Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-30

FDA Approved: AZELASTINE HYDROCHLORIDE — Supplemental Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved a supplemental application for azelastine hydrochloride submitted by Somerset Therapeutics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZELASTINE HYDROCHLORIDE (azelastine hydrochloride)

Snippet

SUPPL AP for AZELASTINE HYDROCHLORIDE (AZELASTINE HYDROCHLORIDE)